 | • レポートコード：MRC23Q35784 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の抗凝固薬市場について調査・分析し、世界の抗凝固薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（注射用抗凝固薬、経口抗凝固薬）、用途別セグメント分析（病院薬局、小売店、オンライン薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott Laboratories、Aspen、AstraZeneca、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Genentech (Roche)、Johnson & Johnson.、Lilly、Merck、Otsuka、Pfizer、Sanofi、The Medicines Companyなどが含まれています。 世界の抗凝固薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、抗凝固薬市場規模を推定する際に考慮しました。本レポートは、抗凝固薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、抗凝固薬に関するビジネス上の意思決定に役立てることを目的としています。 ・抗凝固薬市場の概要 - 抗凝固薬のタイプ別セグメント - 世界の抗凝固薬市場規模：タイプ別分析（注射用抗凝固薬、経口抗凝固薬） - 抗凝固薬の用途別セグメント - 世界の抗凝固薬市場規模：用途別分析（病院薬局、小売店、オンライン薬局、その他） - 世界の抗凝固薬市場規模予測（2018年-2029年） ・抗凝固薬市場の成長トレンド - 抗凝固薬の地域別市場規模（2018年-2029年） - 抗凝固薬市場ダイナミクス - 抗凝固薬の業界動向 - 抗凝固薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：注射用抗凝固薬、経口抗凝固薬 - 世界の抗凝固薬のタイプ別市場規模（2018年-2023年） - 世界の抗凝固薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院薬局、小売店、オンライン薬局、その他 - 世界の抗凝固薬の用途別市場規模（2018年-2023年） - 世界の抗凝固薬の用途別市場規模（2024年-2029年） ・抗凝固薬の地域別市場規模 - 北米の抗凝固薬市場規模（2018年-2029年） - アメリカの抗凝固薬市場規模（2018年-2029年） - ヨーロッパの抗凝固薬市場規模（2018年-2029年） - アジア太平洋の抗凝固薬市場規模（2018年-2029年） - 中国の抗凝固薬市場規模（2018年-2029年） - 日本の抗凝固薬市場規模（2018年-2029年） - 韓国の抗凝固薬市場規模（2018年-2029年） - インドの抗凝固薬市場規模（2018年-2029年） - オーストラリアの抗凝固薬市場規模（2018年-2029年） - 中南米の抗凝固薬市場規模（2018年-2029年） - 中東・アフリカの抗凝固薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Abbott Laboratories、Aspen、AstraZeneca、Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Genentech (Roche)、Johnson & Johnson.、Lilly、Merck、Otsuka、Pfizer、Sanofi、The Medicines Company ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Anticoagulant Medicines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Anticoagulant Medicines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anticoagulant Medicines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Anticoagulant Medicines in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Anticoagulant Medicines include Abbott Laboratories, Aspen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Genentech (Roche) and Johnson & Johnson., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anticoagulant Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant Medicines.
The Anticoagulant Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anticoagulant Medicines market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulant Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Aspen
AstraZeneca
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Genentech (Roche)
Johnson & Johnson.
Lilly
Merck
Otsuka
Pfizer
Sanofi
The Medicines Company
Segment by Type
Injectable Anticoagulant Medicines
Oral Anticoagulant Medicines
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anticoagulant Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Medicines Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Injectable Anticoagulant Medicines
1.2.3 Oral Anticoagulant Medicines
1.3 Market by Application
1.3.1 Global Anticoagulant Medicines Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Medicines Market Perspective (2018-2029)
2.2 Anticoagulant Medicines Growth Trends by Region
2.2.1 Global Anticoagulant Medicines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anticoagulant Medicines Historic Market Size by Region (2018-2023)
2.2.3 Anticoagulant Medicines Forecasted Market Size by Region (2024-2029)
2.3 Anticoagulant Medicines Market Dynamics
2.3.1 Anticoagulant Medicines Industry Trends
2.3.2 Anticoagulant Medicines Market Drivers
2.3.3 Anticoagulant Medicines Market Challenges
2.3.4 Anticoagulant Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Medicines Players by Revenue
3.1.1 Global Top Anticoagulant Medicines Players by Revenue (2018-2023)
3.1.2 Global Anticoagulant Medicines Revenue Market Share by Players (2018-2023)
3.2 Global Anticoagulant Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulant Medicines Revenue
3.4 Global Anticoagulant Medicines Market Concentration Ratio
3.4.1 Global Anticoagulant Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Medicines Revenue in 2022
3.5 Anticoagulant Medicines Key Players Head office and Area Served
3.6 Key Players Anticoagulant Medicines Product Solution and Service
3.7 Date of Enter into Anticoagulant Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulant Medicines Breakdown Data by Type
4.1 Global Anticoagulant Medicines Historic Market Size by Type (2018-2023)
4.2 Global Anticoagulant Medicines Forecasted Market Size by Type (2024-2029)
5 Anticoagulant Medicines Breakdown Data by Application
5.1 Global Anticoagulant Medicines Historic Market Size by Application (2018-2023)
5.2 Global Anticoagulant Medicines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anticoagulant Medicines Market Size (2018-2029)
6.2 North America Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anticoagulant Medicines Market Size by Country (2018-2023)
6.4 North America Anticoagulant Medicines Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anticoagulant Medicines Market Size (2018-2029)
7.2 Europe Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anticoagulant Medicines Market Size by Country (2018-2023)
7.4 Europe Anticoagulant Medicines Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Medicines Market Size (2018-2029)
8.2 Asia-Pacific Anticoagulant Medicines Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anticoagulant Medicines Market Size by Region (2018-2023)
8.4 Asia-Pacific Anticoagulant Medicines Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anticoagulant Medicines Market Size (2018-2029)
9.2 Latin America Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anticoagulant Medicines Market Size by Country (2018-2023)
9.4 Latin America Anticoagulant Medicines Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Medicines Market Size (2018-2029)
10.2 Middle East & Africa Anticoagulant Medicines Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anticoagulant Medicines Market Size by Country (2018-2023)
10.4 Middle East & Africa Anticoagulant Medicines Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anticoagulant Medicines Introduction
11.1.4 Abbott Laboratories Revenue in Anticoagulant Medicines Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Aspen
11.2.1 Aspen Company Detail
11.2.2 Aspen Business Overview
11.2.3 Aspen Anticoagulant Medicines Introduction
11.2.4 Aspen Revenue in Anticoagulant Medicines Business (2018-2023)
11.2.5 Aspen Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anticoagulant Medicines Introduction
11.3.4 AstraZeneca Revenue in Anticoagulant Medicines Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Anticoagulant Medicines Introduction
11.4.4 Bayer Revenue in Anticoagulant Medicines Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Anticoagulant Medicines Introduction
11.5.4 Boehringer Ingelheim Revenue in Anticoagulant Medicines Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Anticoagulant Medicines Introduction
11.6.4 Bristol-Myers Squibb Revenue in Anticoagulant Medicines Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Detail
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Anticoagulant Medicines Introduction
11.7.4 Daiichi Sankyo Revenue in Anticoagulant Medicines Business (2018-2023)
11.7.5 Daiichi Sankyo Recent Development
11.8 Genentech (Roche)
11.8.1 Genentech (Roche) Company Detail
11.8.2 Genentech (Roche) Business Overview
11.8.3 Genentech (Roche) Anticoagulant Medicines Introduction
11.8.4 Genentech (Roche) Revenue in Anticoagulant Medicines Business (2018-2023)
11.8.5 Genentech (Roche) Recent Development
11.9 Johnson & Johnson.
11.9.1 Johnson & Johnson. Company Detail
11.9.2 Johnson & Johnson. Business Overview
11.9.3 Johnson & Johnson. Anticoagulant Medicines Introduction
11.9.4 Johnson & Johnson. Revenue in Anticoagulant Medicines Business (2018-2023)
11.9.5 Johnson & Johnson. Recent Development
11.10 Lilly
11.10.1 Lilly Company Detail
11.10.2 Lilly Business Overview
11.10.3 Lilly Anticoagulant Medicines Introduction
11.10.4 Lilly Revenue in Anticoagulant Medicines Business (2018-2023)
11.10.5 Lilly Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Anticoagulant Medicines Introduction
11.11.4 Merck Revenue in Anticoagulant Medicines Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Otsuka
11.12.1 Otsuka Company Detail
11.12.2 Otsuka Business Overview
11.12.3 Otsuka Anticoagulant Medicines Introduction
11.12.4 Otsuka Revenue in Anticoagulant Medicines Business (2018-2023)
11.12.5 Otsuka Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Detail
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Anticoagulant Medicines Introduction
11.13.4 Pfizer Revenue in Anticoagulant Medicines Business (2018-2023)
11.13.5 Pfizer Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Anticoagulant Medicines Introduction
11.14.4 Sanofi Revenue in Anticoagulant Medicines Business (2018-2023)
11.14.5 Sanofi Recent Development
11.15 The Medicines Company
11.15.1 The Medicines Company Company Detail
11.15.2 The Medicines Company Business Overview
11.15.3 The Medicines Company Anticoagulant Medicines Introduction
11.15.4 The Medicines Company Revenue in Anticoagulant Medicines Business (2018-2023)
11.15.5 The Medicines Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details